Genetic and Epidemiological Approaches to Breast Density and Breast Cancer Risk

乳腺密度和乳腺癌风险的遗传学和流行病学方法

基本信息

  • 批准号:
    9115081
  • 负责人:
  • 金额:
    $ 17.82万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2012
  • 资助国家:
    美国
  • 起止时间:
    2012-08-09 至 2017-07-31
  • 项目状态:
    已结题

项目摘要

DESCRIPTION (provided by applicant): The applicant, Dr. Elad Ziv, is an associate professor of medicine at UCSF and leads a patient oriented research program that investigates genetic susceptibility to common cancers and hematological traits. A major focus of Dr. Ziv's program is the study of genetic factors underlying breast cancer susceptibility. As part of this proposal, Dr. Ziv will search for genetic factors underlying the association between mammographic breast density and breast cancer risk. Mammographic breast density is known to be a strong risk factor for breast cancer and is also a highly heritable trait. Dr. Ziv will analyze a large genome wide association study (GWAS) that his group is generating, comparing 500 women from the top quintile of age and BMI-adjusted breast density to 500 women from the bottom quintile. He will perform a replication analysis of the top 1500 variants in a replication dataset of another 500 women from the top and 500 women from the bottom quintile of age and BMI adjusted density. In addition, his group will search for genetic variants that are associated with both breast densit and breast cancer risk. They will perform a combined analysis of breast density and breast cancer GWAS datasets, using GWAS datasets of breast cancer susceptibility that his group has generated and a publicly available breast cancer GWAS datasets. Dr. Ziv and colleagues will also use next generation sequencing to search for rare variants that may explain the overlap between these traits. In particular, women with a strong family history of breast cancer who are also in the top quintile of age and BMI-adjusted breast density will be selected for whole exome sequencing. As part of this proposal, Dr. Ziv will expand his capacity to mentor junior investigators and develop additional skills to maximize his potential as a mentor. Dr. Ziv has mentored over 15 junior faculty members, fellows, residents and students. He is affiliated with 3 T32 programs for mentoring fellows. As part of this proposal, Dr. Ziv will take on additional mentees at the post-doctoral level and continue to mentor the junior faculty, fellows currently working with him. He will also pursue additional training that will enhance his mentoring and scientific skills.
描述(由申请人提供):申请人Elad Ziv博士是加州大学旧金山分校的医学副教授,领导一个以患者为导向的研究项目,研究常见癌症和血液学特征的遗传易感性。Ziv博士项目的一个主要重点是研究乳腺癌易感性的遗传因素。作为这项提议的一部分。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Elad Ziv其他文献

Elad Ziv的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Elad Ziv', 18)}}的其他基金

Evaluating the clinical implications for ACKR1/DARC associated neutropenia
评估 ACKR1/DARC 相关中性粒细胞减少症的临床意义
  • 批准号:
    10754130
  • 财政年份:
    2023
  • 资助金额:
    $ 17.82万
  • 项目类别:
(8) Genetics of Immune Related Adverse Events and Response to Immunotherapy
(8) 免疫相关不良事件的遗传学和免疫治疗的反应
  • 批准号:
    10436860
  • 财政年份:
    2018
  • 资助金额:
    $ 17.82万
  • 项目类别:
(8) Genetics of Immune Related Adverse Events and Response to Immunotherapy
(8) 免疫相关不良事件的遗传学和免疫治疗的反应
  • 批准号:
    10221641
  • 财政年份:
    2018
  • 资助金额:
    $ 17.82万
  • 项目类别:
(8) Genetics of Immune Related Adverse Events and Response to Immunotherapy
(8) 免疫相关不良事件的遗传学和免疫治疗的反应
  • 批准号:
    10655507
  • 财政年份:
    2018
  • 资助金额:
    $ 17.82万
  • 项目类别:
Genetics of Mammographic Density in Ashkenazi Jews
德系犹太人乳房 X 光密度的遗传学
  • 批准号:
    8571075
  • 财政年份:
    2013
  • 资助金额:
    $ 17.82万
  • 项目类别:
Genetics of Mammographic Density in Ashkenazi Jews
德系犹太人乳房 X 光密度的遗传学
  • 批准号:
    8735003
  • 财政年份:
    2013
  • 资助金额:
    $ 17.82万
  • 项目类别:
Genetics of mammographic density and breast cancer risk in Latinas
拉丁裔乳房 X 光密度和乳腺癌风险的遗传学
  • 批准号:
    10218063
  • 财政年份:
    2012
  • 资助金额:
    $ 17.82万
  • 项目类别:
Genetic and Epidemiological Approaches to Breast Density and Breast Cancer Risk
乳腺密度和乳腺癌风险的遗传学和流行病学方法
  • 批准号:
    8354643
  • 财政年份:
    2012
  • 资助金额:
    $ 17.82万
  • 项目类别:
Genetic and Epidemiological Approaches to Breast Density and Breast Cancer Risk
乳腺密度和乳腺癌风险的遗传学和流行病学方法
  • 批准号:
    8527750
  • 财政年份:
    2012
  • 资助金额:
    $ 17.82万
  • 项目类别:
Genetic and Epidemiological Approaches to Breast Density and Breast Cancer Risk
乳腺密度和乳腺癌风险的遗传学和流行病学方法
  • 批准号:
    8877457
  • 财政年份:
    2012
  • 资助金额:
    $ 17.82万
  • 项目类别:

相似国自然基金

靶向递送一氧化碳调控AGE-RAGE级联反应促进糖尿病创面愈合研究
  • 批准号:
    JCZRQN202500010
  • 批准年份:
    2025
  • 资助金额:
    0.0 万元
  • 项目类别:
    省市级项目
对香豆酸抑制AGE-RAGE-Ang-1通路改善海马血管生成障碍发挥抗阿尔兹海默病作用
  • 批准号:
    2025JJ70209
  • 批准年份:
    2025
  • 资助金额:
    0.0 万元
  • 项目类别:
    省市级项目
AGE-RAGE通路调控慢性胰腺炎纤维化进程的作用及分子机制
  • 批准号:
  • 批准年份:
    2024
  • 资助金额:
    0 万元
  • 项目类别:
    面上项目
甜茶抑制AGE-RAGE通路增强突触可塑性改善小鼠抑郁样行为
  • 批准号:
    2023JJ50274
  • 批准年份:
    2023
  • 资助金额:
    0.0 万元
  • 项目类别:
    省市级项目
蒙药额尔敦-乌日勒基础方调控AGE-RAGE信号通路改善术后认知功能障碍研究
  • 批准号:
  • 批准年份:
    2022
  • 资助金额:
    33 万元
  • 项目类别:
    地区科学基金项目
LncRNA GAS5在2型糖尿病动脉粥样硬化中对AGE-RAGE 信号通路上相关基因的调控作用及机制研究
  • 批准号:
  • 批准年份:
    2022
  • 资助金额:
    10.0 万元
  • 项目类别:
    省市级项目
围绕GLP1-Arginine-AGE/RAGE轴构建探针组学方法探索大柴胡汤异病同治的效应机制
  • 批准号:
    81973577
  • 批准年份:
    2019
  • 资助金额:
    55.0 万元
  • 项目类别:
    面上项目
AGE/RAGE通路microRNA编码基因多态性与2型糖尿病并发冠心病的关联研究
  • 批准号:
    81602908
  • 批准年份:
    2016
  • 资助金额:
    18.0 万元
  • 项目类别:
    青年科学基金项目
高血糖激活滑膜AGE-RAGE-PKC轴致骨关节炎易感的机制研究
  • 批准号:
    81501928
  • 批准年份:
    2015
  • 资助金额:
    18.0 万元
  • 项目类别:
    青年科学基金项目

相似海外基金

"Forens-OMICS" on Human Remains and Biological Fluids for Age-at-Death, Post-Mortem Interval and Time Since Deposition Estimation in Forensic Contexts
关于法医背景下人体遗骸和生物体液死亡年龄、死后间隔和沉积时间估计的“Forens-OMICS”
  • 批准号:
    MR/Y019989/1
  • 财政年份:
    2024
  • 资助金额:
    $ 17.82万
  • 项目类别:
    Fellowship
Regulation of mitochondria-lysosome interactions in muscle: effects of age, biological sex and exercise
肌肉中线粒体-溶酶体相互作用的调节:年龄、生物性别和运动的影响
  • 批准号:
    478339
  • 财政年份:
    2023
  • 资助金额:
    $ 17.82万
  • 项目类别:
    Operating Grants
Epigenetic clocks of biological age and the intergenerational consequences of ageing in the Seychelles warbler
塞舌尔莺生物年龄的表观遗传时钟和衰老的代际后果
  • 批准号:
    2868433
  • 财政年份:
    2023
  • 资助金额:
    $ 17.82万
  • 项目类别:
    Studentship
Evaluating the performance of the 35°C environmental threshold of human survivability with future climate change: quantifying the modifying effects of biological sex, age, and prescription drug use
评估未来气候变化下人类生存能力的 35°C 环境阈值的表现:量化生物性别、年龄和处方药使用的改变影响
  • 批准号:
    473782
  • 财政年份:
    2022
  • 资助金额:
    $ 17.82万
  • 项目类别:
    Fellowship Programs
Establishment of blood-based biomarkers to reflect age-related changes in biological membrane
建立基于血液的生物标志物以反映生物膜与年龄相关的变化
  • 批准号:
    22K19762
  • 财政年份:
    2022
  • 资助金额:
    $ 17.82万
  • 项目类别:
    Grant-in-Aid for Challenging Research (Exploratory)
A dynamic examination of the role of age, biological sex, and acetylcholine (Ach) at different stages of memory using short latency afferent inhibition (SAI), a transcranial magnetic stimulation (TMS)
使用短潜伏期传入抑制 (SAI)、经颅磁刺激 (TMS) 动态检查年龄、生物性别和乙酰胆碱 (Ach) 在记忆不同阶段的作用
  • 批准号:
    576185-2022
  • 财政年份:
    2022
  • 资助金额:
    $ 17.82万
  • 项目类别:
    Vanier Canada Graduate Scholarship Tri-Council - Doctoral 3 years
The Biological Consequences of Age-related Clonal Hematopoiesis
年龄相关克隆造血的生物学后果
  • 批准号:
    10348166
  • 财政年份:
    2021
  • 资助金额:
    $ 17.82万
  • 项目类别:
The Biological Consequences of Age-related Clonal Hematopoiesis
年龄相关克隆造血的生物学后果
  • 批准号:
    10570931
  • 财政年份:
    2021
  • 资助金额:
    $ 17.82万
  • 项目类别:
QUANTITATIVE ASSESSMENT OF BIOLOGICAL AGE AND ITS APPLICATIONS
生物年龄的定量评估及其应用
  • 批准号:
    10833859
  • 财政年份:
    2020
  • 资助金额:
    $ 17.82万
  • 项目类别:
QUANTITATIVE ASSESSMENT OF BIOLOGICAL AGE AND ITS APPLICATIONS
生物年龄的定量评估及其应用
  • 批准号:
    10425342
  • 财政年份:
    2020
  • 资助金额:
    $ 17.82万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了